- Crossject signe une extension géographique de l'accord de commercialisation de ZEPIZURE® en Europe
- Crossject signs a geographic extension of ZEPIZURE® commercialization agreement in Europe
- Crossject annonce le lancement d’une augmentation de capital
- Crossject reports audited financial results for 2023
- Crossject communique ses résultats financiers audités pour 2023
- Crossject : Information relative au nombre total de droits de vote et d'actions composant le capital social
- Crossject trading on Euronext to resume as usual on Wednesday April 3
- La cotation sur l’action de Crossject à Euronext reprendra comme d’habitude le mercredi 3 avril
- Crossject poursuit sa stratégie de développement aux États-Unis et publie ses résultats financiers pour 2023
- Crossject advances in its U.S. Strategy and reports Financial Results for 2023
More ▼
Key statistics
On Friday, Crossject SA (ALCJ:PAR) closed at 1.99, 9.60% above its 52-week low of 1.81, set on Apr 03, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.96 |
---|---|
High | 1.99 |
Low | 1.92 |
Bid | 1.96 |
Offer | 1.98 |
Previous close | 1.97 |
Average volume | 53.54k |
---|---|
Shares outstanding | 41.09m |
Free float | 31.06m |
P/E (TTM) | -- |
Market cap | 80.94m EUR |
EPS (TTM) | -0.2601 EUR |
Data delayed at least 15 minutes, as of May 24 2024 16:21 BST.
More ▼